Ligand ID: WPP Drugbank ID: DB00319(Piperacillin) Indication:For the treatment of polymicrobial infections. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 1uk2 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.38A | 20.87 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 5 / 12 | GLY B 120ASN B 142THR B 25SER B 147GLY B 146 | 1.52A | 20.81 | NoneAZP B 307 (-4.0A)AZP B 307 (-3.5A)NoneNone | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | GLY D 315ASN B 281ASN D 281ASN D 283GLY D 312 | 1.38A | 22.43 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | GLY A 173ASN A 508SER A 502THR A 122GLY A 130 | 1.53A | 18.14 | NoneNone CL A 902 ( 4.3A)NoneNone | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2ajf | ACE2SPIKE PROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | GLY E 391ASN E 424THR E 485GLY E 488ASP A 355 | 1.48A | 20.75 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2amd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.53A | 21.78 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 5 | TYR H 43PRO H 89THR H 85THR G 73 | 1.68A | 15.75 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 5 | TYR A 43PRO A 89THR A 85THR B 73 | 1.77A | 16.80 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 5 | TYR E 43PRO E 89THR E 85THR F 73 | 1.72A | 16.40 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | GLY C 48ASN C 100ASN B 100GLY C 47GLY B 104 | 1.55A | 22.05 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 2gri | NSP3 (SARSr) | 4 / 5 | CYH A 105PRO A 109THR A 87THR A 25 | 1.10A | 16.73 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 2jw8 | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 5 / 12 | GLY A 279THR A 363GLY A 285GLY A 288ASP A 289 | 1.32A | 18.56 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.52A | 20.87 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3d0g | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 6 / 12 | GLY E 391ASN E 424THR E 485GLY E 490GLY E 488ASP A 355 | 1.72A | 22.18 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3d0h | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY E 391ASN E 424THR E 485GLY E 488ASP A 355 | 1.41A | 22.18 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3d0i | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY E 391ASN E 424THR E 485GLY E 488ASP A 355 | 1.51A | 22.18 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY B 173ASN B 508SER B 502THR B 122GLY B 130 | 1.52A | 18.14 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 170ASN A 214GLY B 138SER B 139GLY A 2 | 1.44A | 21.36 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3sci | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | GLY E 391ASN E 424THR E 485GLY E 488ASP A 355 | 1.52A | 19.63 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3scj | ACE2 (Homosapiens) | 5 / 12 | GLY B 173ASN B 508SER B 502THR B 122GLY B 130 | 1.49A | 18.12 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3scj | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | GLY F 391THR F 485GLY F 490GLY B 354ASP B 355 | 1.50A | 19.92 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY A 173ASN A 508SER A 502THR A 122GLY A 130 | 1.36A | 18.12 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3sck | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY F 391ASN F 424THR F 485GLY F 488ASP B 355 | 1.55A | 21.35 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 3scl | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLY F 391ASN F 424THR F 485GLY F 488ASP B 355 | 1.49A | 21.72 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 4m0w | REPLICASEPOLYPROTEIN 1AUBIQUITIN (Bostaurus;SARSr-CoV) | 5 / 12 | GLY B 75ASN A 110GLY A 164GLY A 161ASP A 109 | 1.54A | 14.66 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.54A | 20.87 | None23H A 401 (-4.8A)DMS A 402 (-4.4A)NoneNone | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 4 / 5 | TYR A 252PRO A 300THR A 275THR A 258 | 1.79A | 21.82 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5c8s | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 5 / 12 | GLY D 102ASN C 3THR C 5GLY C -1SER C 0 | 1.32A | 16.44 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5c8t | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 5 / 12 | GLY D 102ASN C 3THR C 5GLY C -1SER C 0 | 1.41A | 16.41 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5e6j | REPLICASEPOLYPROTEIN 1ABUBIQUITIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | GLY E 75ASN D 110GLY D 164GLY D 161ASP D 109 | 1.49A | 14.66 | AYE E 76 (-2.4A)AYE E 76 ( 4.3A)NoneNoneNone | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 5 | CYH C 94TYR A 465PRO C 151THR C 97 | 1.64A | 16.23 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.47A | 20.63 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 5r83 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 5 | CYH A 160PRO A 108THR A 111THR A 175 | 1.79A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | ASN A 119SER A 123ASN A 28SER A 147GLY A 146 | 1.73A | 20.93 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.37A | 20.93 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5tl6 | REPLICASEPOLYPROTEIN 1ABUBIQUITIN-LIKEPROTEIN ISG15 (Homosapiens;SARSr-CoV) | 5 / 12 | GLY C 156ASN D 110GLY D 164GLY D 161ASP D 109 | 1.51A | 14.83 | AYE C 157 ( 2.3A)AYE C 157 ( 4.2A)NoneNoneNone | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5tl7 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | ASN D 14THR D 55GLY D 82GLY D 39ASP D 38 | 1.22A | 21.92 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 5 | TYR A 88PRO A 61THR A 261THR A 215 | 1.75A | 23.12 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 4 / 5 | TYR A 886PRO A 879THR C 693THR A 869 | 1.55A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | THR B 533ASN B 526SER B 310GLY B 311ASP B 312 | 1.39A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 5 | TYR B 88PRO B 61THR B 260THR B 215 | 1.37A | 11.57 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | SER C 362ASN C 424THR C 485GLY C 391GLY C 490 | 1.39A | 11.57 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | TYR A 88PRO A 61THR A 261THR A 215 | 1.67A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY C 580SER A 717ASN A 746ASN C 304GLY C 579 | 1.38A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 5 | TYR B1070PRO B1061THR B1059THR B1098 | 1.53A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY C 580SER A 717ASN A 746ASN C 304GLY C 579 | 1.37A | 11.69 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | GLY D 173ASN D 508SER D 502THR D 122GLY D 130 | 1.46A | 18.45 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.64A | 20.63 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6lzg | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN B 437SER B 443ASN B 439GLY B 496ASP B 405 | 1.41A | 21.30 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.63A | 20.57 | DMS A 403 (-4.0A)NoneNoneNoneNone | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6m1d | ACE2 (Homosapiens) | 5 / 12 | GLY D 395ASN D 572THR D 567GLY D 561SER D 563 | 1.50A | 15.38 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.62A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 301ASN A 214THR C 169SER C 139GLY C 138 | 1.72A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN D 119SER D 123ASN D 28SER D 147GLY D 146 | 1.78A | 20.63 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 71SER D 62THR C 21SER C 121GLY C 120 | 1.60A | 20.63 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 120ASN C 142THR C 25SER C 147GLY C 146 | 1.51A | 20.63 | None3WL C 401 (-4.0A)NoneNoneNone | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER C 123THR C 26ASN C 28SER C 147GLY C 146 | 1.43A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN C 119SER C 123ASN C 28SER C 147GLY C 146 | 1.76A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 71SER D 62THR C 21SER C 121GLY C 120 | 1.53A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 120ASN C 142THR C 25SER C 147GLY C 146 | 1.45A | 20.63 | None3WL C 401 (-4.0A)NoneNoneNone | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER D 121ASN D 119THR D 21SER D 147GLY D 146 | 1.78A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER B 123THR B 26ASN B 28SER B 147GLY B 146 | 1.62A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER D 123THR D 26ASN D 28SER D 147GLY D 146 | 1.47A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.39A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 119SER A 123ASN A 28SER A 147GLY A 146 | 1.74A | 20.63 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 679ASN A 459THR A 462ASN A 628SER A 664 | 1.79A | 14.37 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 683ASN A 568SER A 681GLY A 559SER A 561 | 1.64A | 14.37 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY A 391ASN A 424THR A 485GLY A 490GLY A 488 | 1.47A | 11.07 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR H 159PRO H 216THR H 121THR H 179 | 1.76A | 22.10 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | GLY A 683ASN A 568SER A 681GLY A 559SER A 561 | 1.54A | 14.72 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6nur | NSP12NSP8 (SARSr-CoV) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.71A | 22.73 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 78SER A 111GLY A 79SER A 80ASP B 66 | 1.79A | NoneNoneSO4 A 201 ( 4.8A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 79LYS B 76ASN B 115GLY B 78SER B 111 | 1.78A | NoneSO4 B 201 (-4.0A)NoneNoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 79ASN B 115LYS B 76GLY B 78SER B 111 | 1.69A | NoneNoneSO4 B 201 (-4.0A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 78SER A 111GLY A 79SER A 80ASP B 66 | 1.77A | NoneNoneSO4 A 201 ( 4.8A)NoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 744SER B 746ASN B 978THR A 573ASP A 571 | 1.51A | 12.20 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 744SER A 746ASN A 978THR C 573ASP C 571 | 1.48A | 12.20 | None | ||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 52THR H 57THR H 100 | 1.59A | 22.99 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASN C 437SER C 443ASN C 439GLY C 496ASP C 405 | 1.38A | 19.48 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | ASN C 437SER C 443ASN C 439GLY C 496ASP C 405 | 1.39A | 19.48 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 69GLY L 64SER L 65GLY L 66 | 1.39A | 19.01 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 69GLY L 64SER L 65GLY L 66 | 1.48A | 19.01 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 52THR H 57THR H 100 | 1.57A | 22.99 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | GLY H 28ASN H 76GLY H 26SER H 25GLY H 24 | 1.53A | 22.99 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146ASN A 119THR A 21SER A 144GLY A 143 | 1.71A | NoneNoneNoneX77 A 401 (-3.4A)X77 A 401 (-3.6A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.55A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146ASN A 119THR A 21SER A 144GLY A 143 | 1.76A | NoneNoneNoneX77 A 401 (-3.4A)X77 A 401 (-3.6A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 79ASN B 117LYS B 76GLY B 78SER B 111 | 1.73A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 79ASN B 117LYS B 76GLY B 78SER B 111 | 1.77A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 130ASN B 101ASN B 99SER B 128GLY B 97 | 1.68A | MES B 201 ( 3.4A)NoneNoneMES B 201 ( 4.5A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 79LYS B 76ASN B 115GLY B 78SER B 111 | 1.74A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 130ASN B 101ASN B 99SER B 128GLY B 97 | 1.64A | MES B 201 ( 3.4A)NoneNoneMES B 201 ( 4.5A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLY C 38THR C 34LYS C 91SER C 85GLY C 81 | 1.40A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLY C 38THR C 34LYS C 91SER C 85GLY C 81 | 1.52A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6w9q | 3C-LIKE PROTEINASEPEPTIDE, NSP9 FUSION (SARS-CoV-2) | 5 / 12 | GLY A 100ASN A 33ASN A 98GLY A 104SER A 105 | 1.62A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.69A | MES A 201 (-3.2A)NoneNoneMES A 201 (-4.4A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.72A | MES A 201 (-3.2A)NoneNoneMES A 201 (-4.4A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.72A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.64A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 334ASN A 305ASN A 303SER A 332GLY A 301 | 1.67A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 334ASN A 305ASN A 303SER A 332GLY A 301 | 1.59A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 278THR A 362GLY A 284GLY A 287ASP A 288 | 1.42A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY D 278THR D 362GLY D 284GLY D 287ASP D 288 | 1.48A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 278THR B 362GLY B 284GLY B 287ASP B 288 | 1.47A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY F 278THR F 362GLY F 284GLY F 287ASP F 288 | 1.43A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 316SER B 318GLY A 284GLY A 287ASP A 288 | 1.63A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 316SER C 318GLY D 284GLY D 287ASP D 288 | 1.65A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY E 278THR E 362GLY E 284GLY E 287ASP E 288 | 1.47A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 316SER A 318GLY B 284GLY B 287ASP B 288 | 1.64A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY E 316SER E 318GLY F 284GLY F 287ASP F 288 | 1.64A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY F 278THR F 362GLY F 284GLY F 287ASP F 288 | 1.43A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 278THR B 362GLY B 284GLY B 287ASP B 288 | 1.47A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 278THR C 362GLY C 284GLY C 287ASP C 288 | 1.44A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY D 316SER D 318GLY C 284GLY C 287ASP C 288 | 1.61A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 278THR A 362GLY A 284GLY A 287ASP A 288 | 1.42A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY D 316SER D 318GLY C 284GLY C 287ASP C 288 | 1.63A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY E 278THR E 362GLY E 284GLY E 287ASP E 288 | 1.47A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 278THR C 362GLY C 284GLY C 287ASP C 288 | 1.43A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 316SER C 318THR D 296GLY D 284GLY D 287 | 1.80A | NoneNone CL D 401 ( 4.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY B 316SER B 318GLY A 284GLY A 287ASP A 288 | 1.61A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY E 316SER E 318GLY F 284GLY F 287ASP F 288 | 1.63A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 316SER C 318GLY D 284GLY D 287ASP D 288 | 1.64A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY D 278THR D 362GLY D 284GLY D 287ASP D 288 | 1.48A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.63A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.44A | NoneU5G A 401 (-3.5A)NoneNoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY C 130ASN C 101ASN C 99SER C 128GLY C 97 | 1.70A | APR C 201 (-3.0A)NoneNoneAPR C 201 (-4.4A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY D 130ASN D 101ASN D 99SER D 128GLY D 97 | 1.78A | APR D 201 (-3.2A)NoneNoneAPR D 201 (-4.3A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY B 130ASN B 101ASN B 99SER B 128GLY B 97 | 1.72A | APR B 201 (-3.3A)NoneNoneAPR B 201 (-4.5A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.75A | APR A 201 (-3.5A)NoneNoneAPR A 201 (-4.4A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY B 130ASN B 101ASN B 99SER B 128GLY B 97 | 1.78A | APR B 201 (-3.3A)NoneNoneAPR B 201 (-4.5A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY C 130ASN C 101ASN C 99SER C 128GLY C 97 | 1.75A | APR C 201 (-3.0A)NoneNoneAPR C 201 (-4.4A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 130ASN A 101ASN A 99SER A 128GLY A 97 | 1.71A | APR A 201 (-3.5A)NoneNoneAPR A 201 (-4.4A)None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 5 | TYR A7040PRO A6805THR A6846THR A6833 | 1.58A | 23.44 | None | ||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 5 | TYR A7040PRO A6805THR A6846THR A6833 | 1.60A | 23.44 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.46A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146ASN A 119THR A 21SER A 144GLY A 143 | 1.73A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.56A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146ASN A 119THR A 21SER A 144GLY A 143 | 1.75A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.63A | 20.93 | None | ||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 5 | TYR A 46PRO A 33THR A 36THR A 9 | 1.54A | 19.70 | None | ||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6yi3 | NUCLEOPROTEIN (SARS-CoV-2) | 4 / 5 | TYR A 46PRO A 33THR A 36THR A 9 | 1.51A | 19.70 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN C 22THR C 75GLY C 70SER C 71GLY C 72 | 1.46A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.33A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 437SER A 443ASN A 439GLY A 496ASP A 405 | 1.37A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.48A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 334ASN A 532THR A 523LYS E 529GLY A 526 | 1.22A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR B 32PRO B 53THR B 58THR B 104 | 1.58A | 22.91 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.38A | NoneNoneNoneMLI E 903 ( 4.4A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN C 22THR C 75GLY C 70SER C 71GLY C 72 | 1.37A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR B 32PRO B 53THR B 58THR B 104 | 1.60A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 437SER A 443ASN A 439GLY A 496ASP A 405 | 1.38A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 70SER L 69SER L 71GLY L 72ASP L 76 | 1.75A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.38A | NoneNoneNoneMLI E 903 ( 4.4A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.45A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6yla | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.45A | 22.91 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 334ASN A 532THR A 523LYS E 529GLY A 526 | 1.21A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.46A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.49A | 22.91 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | GLY H 28ASN H 77GLY H 26SER H 25GLY H 24 | 1.40A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | SER L 32ASN L 35ASN L 37SER L 28GLY L 74 | 1.65A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.43A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.31A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 70SER L 69SER L 71GLY L 72ASP L 76 | 1.73A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.34A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.31A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | SER L 32ASN L 35ASN L 37SER L 28GLY L 74 | 1.75A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.53A | NoneP6N A 502 (-3.4A)NoneNoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | ASN A 119SER A 123ASN A 28SER A 147GLY A 146 | 1.72A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 120ASN A 142THR A 25SER A 147GLY A 146 | 1.47A | NoneP6N A 502 (-3.4A)NoneNoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.35A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | ASN C 22THR C 75GLY C 70SER C 71GLY C 72 | 1.33A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 437SER A 443ASN A 439GLY A 496ASP A 405 | 1.39A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.44A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.38A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 5 | TYR B 32PRO B 53THR B 58THR B 104 | 1.49A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | ASN L 22THR L 75GLY L 70SER L 71GLY L 72 | 1.32A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.45A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN E 437SER E 443ASN E 439GLY E 496ASP E 405 | 1.38A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 5 | TYR B 32PRO B 53THR B 58THR B 104 | 1.46A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY L 70SER L 69SER L 71GLY L 72ASP L 76 | 1.76A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASN A 437SER A 443ASN A 439GLY A 496ASP A 405 | 1.38A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | ASN C 22THR C 75GLY C 70SER C 71GLY C 72 | 1.45A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY C 70SER C 69SER C 71GLY C 72ASP C 76 | 1.75A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 6yor | IGG H CHAIN (Homosapiens) | 4 / 5 | TYR H 32PRO H 53THR H 58THR H 104 | 1.48A | 22.91 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.60A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY E 130ASN B 54ASN B 59GLY E 133GLY B 47 | 1.76A | EPE E 202 ( 4.5A)NoneNoneNoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN D 115ASN A 115GLY A 78SER A 111 | 1.32A | NoneEDO D 201 (-3.6A)EDO D 201 (-3.4A)NoneEDO D 202 (-3.6A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 48ASN B 40GLY B 51GLY B 46ASP E 135 | 1.72A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY E 133GLY E 130 | 1.74A | NoneNoneNoneNoneEPE E 202 ( 4.5A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 48ASN B 37GLY B 51GLY B 46ASP E 135 | 1.75A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY B 47GLY E 130 | 1.77A | NoneNoneNoneNoneEPE E 202 ( 4.5A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY E 133GLY E 130 | 1.73A | NoneNoneNoneNoneEPE E 202 ( 4.5A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN A 115ASN D 115GLY D 78SER D 111 | 1.31A | NoneEDO D 201 (-3.4A)EDO D 201 (-3.6A)NoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 48ASN B 37GLY B 51GLY B 46ASP E 135 | 1.76A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.76A | EPE C 202 (-3.4A)NoneNoneNoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY B 47GLY E 130 | 1.74A | NoneNoneNoneNoneEPE E 202 ( 4.5A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 48ASN B 40GLY B 51GLY B 46ASP E 135 | 1.71A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN A 115ASN D 115GLY D 78SER D 111 | 1.32A | NoneEDO D 201 (-3.4A)EDO D 201 (-3.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.76A | EPE C 202 (-3.4A)NoneNoneNoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN D 115ASN A 115GLY A 78SER A 111 | 1.30A | NoneEDO D 201 (-3.6A)EDO D 201 (-3.4A)NoneEDO D 202 (-3.6A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN A 37SER A 80GLY A 78GLY A 97 | 1.75A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN A 115ASN D 115GLY D 78SER D 111 | 1.34A | EDO D 203 (-3.1A)EDO A 207 (-3.9A)EDO A 207 ( 3.7A)NoneEDO A 206 (-3.3A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.74A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN D 115ASN A 115GLY A 78SER A 111 | 1.35A | NoneEDO A 207 ( 3.7A)EDO A 207 (-3.9A)NoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY B 47GLY E 130 | 1.64A | EDO B 202 (-3.9A)NoneNoneAPR B 201 (-3.6A)APR E 201 (-3.2A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.75A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN D 37SER D 80GLY D 78GLY D 97 | 1.75A | EDO D 203 (-3.1A)NoneEDO D 203 (-3.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN D 115ASN A 115GLY A 78SER A 111 | 1.34A | NoneEDO A 207 ( 3.7A)EDO A 207 (-3.9A)NoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY E 133GLY E 130 | 1.71A | EDO B 202 (-3.9A)NoneNoneNoneAPR E 201 (-3.2A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN D 37SER D 80GLY D 78GLY D 97 | 1.75A | EDO D 203 (-3.1A)NoneEDO D 203 (-3.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN A 37SER A 80GLY A 78GLY A 97 | 1.75A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 130ASN B 101ASN B 99SER B 128GLY B 97 | 1.76A | APR B 201 (-3.2A)NoneNoneAPR B 201 (-4.3A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 79ASN B 37SER B 80GLY B 78GLY B 97 | 1.74A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY E 133GLY E 130 | 1.70A | EDO B 202 (-3.9A)NoneNoneNoneAPR E 201 (-3.2A) | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 46ASN B 59ASN B 54GLY B 47GLY E 130 | 1.62A | EDO B 202 (-3.9A)NoneNoneAPR B 201 (-3.6A)APR E 201 (-3.2A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY E 79ASN E 37SER E 80GLY E 78GLY E 97 | 1.76A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79ASN A 115ASN D 115GLY D 78SER D 111 | 1.35A | EDO D 203 (-3.1A)EDO A 207 (-3.9A)EDO A 207 ( 3.7A)NoneEDO A 206 (-3.3A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 79ASN B 37SER B 80GLY B 78GLY B 97 | 1.74A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY E 79ASN E 37SER E 80GLY E 78GLY E 97 | 1.76A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN C 115ASN A 115GLY A 78SER A 111 | 1.33A | EDO A 204 (-3.6A)EDO A 202 (-3.6A)EDO A 202 ( 3.5A)NoneEDO C 205 (-3.5A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.74A | NoneNoneEDO A 204 ( 4.9A)NoneNone | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79ASN C 115ASN A 115GLY A 78SER A 111 | 1.33A | EDO A 204 (-3.6A)EDO A 202 (-3.6A)EDO A 202 ( 3.5A)NoneEDO C 205 (-3.5A) | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN A 115ASN C 115GLY C 78SER C 111 | 1.34A | NoneEDO A 202 ( 3.5A)EDO A 202 (-3.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN A 115ASN C 115GLY C 78SER C 111 | 1.34A | NoneEDO A 202 ( 3.5A)EDO A 202 (-3.6A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79ASN C 37SER C 80GLY C 78GLY C 97 | 1.74A | NoneNoneEDO A 204 ( 4.9A)NoneNone | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.58A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.70A | 23.64 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 679ASN A 459THR A 462ASN A 628SER A 664 | 1.63A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 385ASN A 404ASN A 403SER A 672GLY A 671 | 1.61A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.69A | 23.64 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | ASN A 119SER A 123ASN A 28SER A 147GLY A 146 | 1.72A | None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | SER A 123THR A 26ASN A 28SER A 147GLY A 146 | 1.37A | None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.66A | 23.74 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 679ASN A 459THR A 462ASN A 628SER A 664 | 1.76A | None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.66A | 23.74 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 503SER A 501THR A 567GLY A 559ASP A 684 | 1.79A | None U T 9 ( 2.7A)None U T 10 ( 3.5A)None | |||
![]() | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.62A | 23.74 | None | ||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 385ASN A 404ASN A 403SER A 672GLY A 671 | 1.56A | None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 503SER A 501GLY A 559GLY A 683ASP A 684 | 1.80A | None U T 9 ( 2.7A) U T 10 ( 3.5A) U T 10 ( 3.1A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 683ASN A 568SER A 681GLY A 559SER A 561 | 1.71A | U T 10 ( 3.1A)NoneNone U T 10 ( 3.5A)None | |||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 503SER A 501THR A 567GLY A 559ASP A 684 | 1.78A | None U T 9 ( 2.7A)None U T 10 ( 3.5A)None | |||
![]() | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 5 | TYR B 138PRO B 133THR A 393THR B 187 | 1.60A | 23.74 | None | ||
![]() | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 503SER A 501GLY A 559GLY A 683ASP A 684 | 1.80A | None U T 9 ( 2.7A) U T 10 ( 3.5A) U T 10 ( 3.1A)None | |||
![]() | 3Q07_A_WPPA300_1 (BETA-LACTAMASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 679ASN A 459THR A 462ASN A 628SER A 664 | 1.66A | None |